Søby, S., Prestwich, R., Gyldenkerne, N., Maare, C., Lonkvist, C. K., Andersen, M., … Eriksen, J. G. (2025). Pembrolizumab as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multi-institutional DAHANCA cohort study. Acta Oncologica, 64, 1269–1275. https://doi.org/10.2340/1651-226X.2025.44327